S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)

Surface Oncology - SURF SEC Filings & 10K Form

$1.73
-0.04 (-2.26%)
(As of 08/18/2022 05:26 PM ET)
Add
Compare
Today's Range
$1.70
$1.77
50-Day Range
$1.42
$2.10
52-Week Range
$1.37
$8.38
Volume
465,855 shs
Average Volume
731,037 shs
Market Capitalization
$100.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.50

Recent Surface Oncology SEC Filings

DateFilerForm TypeView
08/09/2022
8:46 AM
ARK Investment Management LLC (Filed by)
Surface Oncology (Subject)
Form SC 13G/A
08/05/2022
7:01 PM
RATH HENRY C. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2022
7:01 PM
ONEILL ALISON (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2022
7:00 PM
ROSS ROBERT W. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2022
7:00 PM
FEES JESSICA (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2022
7:00 PM
Palombella Vito J. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/03/2022
5:56 AM
Surface Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/03/2022
5:51 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2022
7:05 PM
Brunn Carsten (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2022
7:00 PM
Brunn Carsten (Reporting)
Surface Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/29/2022
6:27 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2022
7:00 PM
Sigal Charles Elliott (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
7:00 PM
Shanafelt Armen (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
7:00 PM
Surface Oncology (Issuer)
Torres Denice (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
7:00 PM
Stelzer Laurie (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
7:00 PM
Hickey Benjamin (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
7:00 PM
Ibrahim Ramy (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
7:00 PM
GRAYZEL DAVID S. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
7:00 PM
Goater Jeff (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2022
6:00 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2022
2:12 PM
BlackRock Inc. (Filed by)
Surface Oncology (Subject)
Form SC 13G
05/09/2022
6:09 AM
Surface Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2022
6:00 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2022
6:04 AM
Surface Oncology (Filer)
Form DEFA14A
04/26/2022
6:02 AM
Surface Oncology (Filer)
Form DEF 14A
08/15/2021
11:15 PM
Surface Oncology (Filer)
Form EFFECT
08/05/2021
4:16 PM
Surface Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/05/2021
6:06 AM
Surface Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/05/2021
6:02 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2021
11:05 AM
ARK Investment Management LLC (Filed by)
Surface Oncology (Subject)
Form SC 13G/A
07/08/2021
6:10 AM
Surface Oncology (Issuer)
Torres Denice (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/08/2021
6:05 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2021
7:30 PM
Goater Jeff (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
3:30 PM
GRAYZEL DAVID S. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
3:30 PM
Ibrahim Ramy (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
3:30 PM
Sigal Charles Elliott (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
3:30 PM
Stelzer Laurie (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
3:30 PM
Shanafelt Armen (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
3:30 PM
MCDONOUGH GEOFF (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
7:00 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2021
6:15 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2021
5:50 PM
ONEILL ALISON (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2021
5:50 PM
RATH HENRY C. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2021
5:47 PM
ONEILL ALISON (Reporting)
Surface Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/05/2021
5:47 PM
RATH HENRY C. (Reporting)
Surface Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/05/2021
5:45 PM
FEES JESSICA (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2021
5:40 AM
Surface Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2021
5:31 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2021
6:00 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2021
6:05 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2021
5:49 AM
Surface Oncology (Filer)
Form DEFA14A
04/27/2021
5:46 AM
Surface Oncology (Filer)
Form DEF 14A
04/02/2021
7:25 PM
Goater Jeff (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2021
7:00 PM
ROSS ROBERT W. (Reporting)
Surface Oncology (Issuer)
Form 4/A
03/09/2021
6:21 AM
Surface Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/09/2021
6:13 AM
Surface Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/09/2021
6:07 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2021
6:06 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2021
7:18 PM
ROSS ROBERT W. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:17 PM
Palombella Vito J. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:17 PM
Nogelo Liisa I (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:16 PM
FEES JESSICA (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2021
6:02 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/18/2021
7:00 PM
ROSS ROBERT W. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2021
4:08 PM
Lilly Ventures Fund I LLC (Filed by)
Surface Oncology (Subject)
Form SC 13G
02/12/2021
12:28 PM
New Enterprise Associates 14, L.P. (Filed by)
Surface Oncology (Subject)
Form SC 13G/A
02/11/2021
4:10 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Surface Oncology (Subject)
Form SC 13G/A
02/11/2021
6:15 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2021
5:33 AM
LV Management Group, LLC (Filed by)
Surface Oncology (Subject)
Form SC 13G/A
02/09/2021
7:00 PM
FEES JESSICA (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
7:00 PM
Goater Jeff (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
4:24 PM
Novartis Institutes for BioMedical Research, Inc. (Filed by)
Surface Oncology (Subject)
Form SC 13G/A
02/03/2021
7:00 PM
Goater Jeff (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
7:00 PM
FEES JESSICA (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
12:03 PM
Atlas Venture Fund IX, L.P. (Filed by)
Surface Oncology (Subject)
Form SC 13G/A
01/21/2021
7:17 PM
Goater Jeff (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2021
7:00 PM
ROSS ROBERT W. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
5:02 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/21/2020
2:35 PM
GRAYZEL DAVID S. (Reporting)
Surface Oncology (Issuer)
Form 4/A
12/21/2020
2:35 PM
Atlas Venture Associates IX, L.P. (Reporting)
Atlas Venture Associates IX, LLC (Reporting)
Atlas Venture Fund IX, L.P. (Reporting)
Surface Oncology (Issuer)
Form 4/A
12/21/2020
12:32 PM
GRAYZEL DAVID S. (Reporting)
Surface Oncology (Issuer)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2020
12:32 PM
Atlas Venture Associates IX, L.P. (Reporting)
Atlas Venture Associates IX, L.P. (Reporting)
Atlas Venture Associates IX, LLC (Reporting)
Atlas Venture Associates IX, LLC (Reporting)
Atlas Venture Fund IX, L.P. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
7:00 PM
ROSS ROBERT W. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
6:05 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2020
7:00 PM
ROSS ROBERT W. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2020
8:15 AM
FMR LLC (Filed by)
Surface Oncology (Subject)
Form SC 13G
11/27/2020
7:00 PM
FEES JESSICA (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2020
6:00 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2020
7:00 PM
ROSS ROBERT W. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2020
6:00 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2020
5:58 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/10/2020
5:07 AM
Surface Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/10/2020
5:02 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
3:01 PM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
7:00 AM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2020
7:30 PM
FEES JESSICA (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2020
3:01 PM
Surface Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2020
7:02 PM
ROSS ROBERT W. (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2020
3:17 PM
EcoR1 Capital, LLC (Reporting)
Surface Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
5:26 AM
Surface Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
This page (NASDAQ:SURF) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.